CO.DON AG INH. O.N.

F:CNW Germany Biotechnology
Market Cap
$411.46K
€400.85K EUR
Market Cap Rank
#37974 Global
#5019 in Germany
Share Price
€0.02
Change (1 day)
+15.38%
52-Week Range
€0.01 - €0.04
All Time High
€23.42
About

co.don AG does not have significant operations. Previously, the company was engaged in the development, production, and marketing of biopharmaceutical products for joint preservation and the regenerative treatment of articular cartilage defects worldwide. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.

CO.DON AG INH. O.N. (CNW) - Net Assets

Latest net assets as of : €- EUR

Based on the latest financial reports, CO.DON AG INH. O.N. (CNW) has net assets worth €- EUR as of .

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €-
% of Total Assets 0%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

CO.DON AG INH. O.N. - Net Assets Trend (None–None)

This chart illustrates how CO.DON AG INH. O.N.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for CO.DON AG INH. O.N. (None–None)

The table below shows the annual net assets of CO.DON AG INH. O.N. from None to None.

Year Net Assets Change
No yearly data available.

Equity Component Analysis

This analysis shows how different components contribute to CO.DON AG INH. O.N.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • No equity composition insights available.

CO.DON AG INH. O.N. Competitors by Market Cap

The table below lists competitors of CO.DON AG INH. O.N. ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in CO.DON AG INH. O.N.'s equity between the two most recent reporting periods.

Insufficient data available to analyze equity growth attribution.

Book Value vs Market Value Analysis

This analysis compares CO.DON AG INH. O.N.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Insufficient data available to analyze book value vs market value.

Capital Efficiency Dashboard

This dashboard shows how efficiently CO.DON AG INH. O.N. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Insufficient data available to analyze capital efficiency metrics.

Industry Comparison

This section compares CO.DON AG INH. O.N.'s net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $1,291,084,078
  • Average return on equity (ROE) among peers: -24.49%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
CO.DON AG INH. O.N. (CNW) €- N/A N/A $387.77K
09R (09R) $-3.01 Million 0.00% 0.00x $11.12 Million
IDORSIA AG (19T) $-968.72 Million 0.00% 0.00x $532.51 Million
1S90 (1S90) $-44.86 Million 0.00% 0.00x $51.72 Million
Strategic Partners A/S (1TB0) $14.24 Million -182.90% 0.36x $1.31 Million
25K0 (25K0) $-16.66 Million 0.00% 0.00x $102.39 Million
2BO (2BO) $-37.78 Million 0.00% 0.00x $6.23 Million
Intervacc AB (publ) (2E9) $237.93 Million -43.23% 0.09x $3.46 Million
2F5 (2F5) $-4.57 Million 0.00% 0.00x $2.14 Million
2H0 (2H0) $14.92 Million -17.30% 0.56x $9.25 Million
GNI Group Ltd (3G6) $13.72 Billion -1.46% 0.26x $772.60 Million